Catheter Precision (VTAK) Asset Writedowns and Impairment (2018 - 2023)

Catheter Precision (VTAK) has reported Asset Writedowns and Impairment for 4 consecutive years, with -$4.8 million the latest figure, recorded in Q4 2023.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$4.8 million in Q4 2023; TTM through Sep 2023 was $5.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment was -$4.8 million for Q4 2023 at Catheter Precision, up from -$56.1 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $56.1 million in Q1 2023 and troughed at -$56.1 million in Q3 2023.
• A 3-year average of $46300.0 and a median of $20500.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 811.76% in 2020, down 95.87% in 2020.
• Over 3 years, Asset Writedowns and Impairment stood at $17000.0 in 2019, then soared by 811.76% to $155000.0 in 2020, then plunged by 3196.77% to -$4.8 million in 2023.
• The last three Asset Writedowns and Impairment figures came in at -$4.8 million (Q4 2023), -$56.1 million (Q3 2023), and $4.8 million (Q2 2023), per Business Quant data.